195 related articles for article (PubMed ID: 35413826)
1. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
[TBL] [Abstract][Full Text] [Related]
2. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer.
Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E
Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.
Strijker M; van der Sijde F; Suker M; Boermeester MA; Bonsing BA; Bruno MJ; Busch OR; Doukas M; van Eijck CH; Gerritsen A; Groot Koerkamp B; Haj Mohammad N; van Hilst J; de Hingh IH; van Hooft JE; Luyer MD; Quintus Molenaar I; Verheij J; Waasdorp C; Wilmink JW; Besselink MG; van Laarhoven HW; Bijlsma MF;
HPB (Oxford); 2021 Dec; 23(12):1886-1896. PubMed ID: 34103247
[TBL] [Abstract][Full Text] [Related]
4. A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial‑mesenchymal transition.
Oh HH; Park YL; Park SY; Joo YE
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866761
[TBL] [Abstract][Full Text] [Related]
5. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
6. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
[TBL] [Abstract][Full Text] [Related]
7. ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy.
Piotrowski KB; Blasco LP; Samsøe-Petersen J; Eefsen RL; Illemann M; Oria VO; Campos KIA; Lopresti AM; Albrechtsen R; Sørensen CS; Sun XF; Kveiborg M; Gnosa S
Cancer Gene Ther; 2023 Oct; 30(10):1369-1381. PubMed ID: 37495855
[TBL] [Abstract][Full Text] [Related]
8. ADAM12 is an independent predictor of poor prognosis in liver cancer.
Du S; Sun L; Wang Y; Zhu W; Gao J; Pei W; Zhang Y
Sci Rep; 2022 Apr; 12(1):6634. PubMed ID: 35459884
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
10. ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Córdoba A; Azúa YR; Aguiar B; Beloqui R; Armendáriz P; Arriola M; Martín-Sánchez E; Guerrero-Setas D
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019179
[TBL] [Abstract][Full Text] [Related]
11. A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.
Gao Y; Wu C; Huang J; Huang Z; Jin Z; Guo S; Tao X; Lu S; Zhang J; Zhang F; Zhai Y; Shi R; Ye P; Wu J
Comput Biol Med; 2023 Nov; 166():107562. PubMed ID: 37847945
[TBL] [Abstract][Full Text] [Related]
12. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
13. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
Cheon DJ; Li AJ; Beach JA; Walts AE; Tran H; Lester J; Karlan BY; Orsulic S
Carcinogenesis; 2015 Jul; 36(7):739-47. PubMed ID: 25926422
[TBL] [Abstract][Full Text] [Related]
14. Increased ADAM12 Expression Predicts Poor Prognosis in Cervical Cancer Patients before General Anesthesia.
Ma X; Wu Z; Zhang J; Shao X; Shen H
Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
16. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy.
Veenstra VL; Damhofer H; Waasdorp C; van Rijssen LB; van de Vijver MJ; Dijk F; Wilmink HW; Besselink MG; Busch OR; Chang DK; Bailey PJ; Biankin AV; Kocher HM; Medema JP; Li JS; Jiang R; Pierce DW; van Laarhoven HWM; Bijlsma MF
Oncogenesis; 2018 Nov; 7(11):87. PubMed ID: 30442938
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
[TBL] [Abstract][Full Text] [Related]
18. Expression of CDCP1 and ADAM12 in the ovarian cancer microenvironment.
Vlad C; Kubelac P; Onisim A; Fetica B; Fulop A; Irimie A; Achimas-Cadariu P
J BUON; 2016; 21(4):973-978. PubMed ID: 27685922
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
